Based in Epalinges, Pilatus Biosciences focuses on developing a first-in-class antibody targeting metabolic checkpoints. The company is transforming cancer treatment by developing innovative therapies that strengthen the immune system to fight cancer.
Cooperation possibilities
At Pilatus Biosciences, our innovative treatments are designed to target hard-to-treat cancers that don’t respond to existing options, offering new possibilities for patients facing aggressive diseases and improving survival and quality of life for patients while opening new frontiers in medicine.
- https://www.pilatusbio.com
- Send an email
- Raven Lin
Some insights
We aim to revolutionize healthcare by creating therapies that go beyond extending survival, improving patients’ quality of life, and shaping a future where previously untreatable conditions become manageable
We believe in the power of scientific innovation and ethical integrity. Through rigorous research, patient-centric development, collaboration with the global medical community, and purpose-driven innovation, we strive to make tangible advances in cancer treatment and improve patients' lives.
Our team's core strengths are its global expertise, diverse innovation, and collaborative nature. We excel in overcoming challenges with determination and adaptability. In the future, we aim to integrate new talents with skills in emerging technologies to continue advancing life-changing treatments.
The Swiss biotech ecosystem can support us by fostering collaboration among academia, industry, and startups. Providing access to funding, infrastructure, and talent will drive innovation. Regulatory flexibility and international partnerships can help us advance groundbreaking therapies.
We seek to connect with universities, industry leaders, startups, and regulatory agencies. These collaborations will help us innovate, access essential resources, and unlock new ways to treat cancer.